Harr Steve

CFO & Head, Corp. Development at Juno Therapeutics, Inc.

Sold, on record
$5.2M
Dollars the filings state
Form 4 sales
7
Latest Dec 21, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Dec 10, 2015 2015

    Sold 35,000 shares at $46.43 ($1.6M)

    Harr Steve, Officer

    Sold 4.4% of holdings ($37.1M position)765,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Mar 1, 2016 +82 days

    Sold 30,000 shares at $37.58 ($1.1M)

    Harr Steve, Officer

    Sold 3.9% of holdings ($28.7M position)735,000 shares leftFiling

  3. 3 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Mar 4, 2016 +3 days

    Sold 5,000 shares at $45.00 ($225k)

    Harr Steve, Officer

    Sold 0.7% of holdings ($33.1M position)730,000 shares leftFiling

  4. 4 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Jun 10, 2016 +98 days

    Sold 30,000 shares at $43.32 ($1.3M)

    Harr Steve, CFO & Head, Corp. Development

    Sold 4.1% of holdings ($31.6M position)700,000 shares left1x usual sizeFiling

  5. 5 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Jun 27, 2017 +382 days

    Sold 8,750 shares at $30.00 ($263k)

    Harr Steve, CFO & Head, Corp. Development

    Sold 1.2% of holdings ($22.1M position)727,439 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Jul 3, 2017 +6 days

    Sold 8,750 shares at $30.00 ($263k)

    Harr Steve, CFO & Head, Corp. Development

    Sold 1.2% of holdings ($22.1M position)727,439 shares left0.3x usual sizeFiling

  7. 7 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Dec 21, 2017 +171 days

    Sold 8,750 shares at $44.77 ($392k)

    Harr Steve, CFO & Head, Corp. Development

    Sold 1.1% of holdings ($34.6M position)763,332 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Harr Steve
Source
Dec 21, 2017Dec 22, 2017Juno Therapeutics, Inc.CFO & Head, Corp. DevelopmentForm 4 sale8,750$392k1.1%Plan not statedSEC
Jul 3, 2017Jul 5, 2017Juno Therapeutics, Inc.CFO & Head, Corp. DevelopmentForm 4 sale8,750$263k1.2%Plan not statedSEC
Jun 27, 2017Jun 29, 2017Juno Therapeutics, Inc.CFO & Head, Corp. DevelopmentForm 4 sale8,750$263k1.2%Plan not statedSEC
Jun 10, 2016Jun 13, 2016Juno Therapeutics, Inc.CFO & Head, Corp. DevelopmentForm 4 sale30,000$1.3M4.1%Plan not statedSEC
Mar 4, 2016Mar 4, 2016Juno Therapeutics, Inc.OfficerForm 4 sale5,000$225k0.7%Plan not statedSEC
Mar 1, 2016Mar 2, 2016Juno Therapeutics, Inc.OfficerForm 4 sale30,000$1.1M3.9%Plan not statedSEC
Dec 10, 2015Dec 11, 2015Juno Therapeutics, Inc.OfficerForm 4 sale35,000$1.6M4.4%Plan not statedSEC